INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
97 hedge funds and large institutions have $42.5M invested in Inozyme Pharma in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
8.83% less ownership
Funds ownership: 81.56% → 72.73% (-8.8%)
35% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 20
71% less capital invested
Capital invested by funds: $145M → $42.5M (-$103M)
Holders
97
Holding in Top 10
2
Calls
$13K
Puts
$1K
Top Buyers
| 1 | +$202K | |
| 2 | +$142K | |
| 3 | +$130K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$114K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$100K |
Top Sellers
| 1 | -$6.15M | |
| 2 | -$797K | |
| 3 | -$588K | |
| 4 |
Millennium Management
New York
|
-$580K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$555K |
